---
$id: https://graph.org.ai/products/commodity/51332509
$type: Product
source: UNSPSC
code: "51332509"
title: "Fluanisone"
class: "51332500"
classTitle: "Antipsychotic butyrophenones"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fluanisone

**UNSPSC Code**: 51332509
**Class**: [Antipsychotic butyrophenones](Antipsychotic butyrophenones.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C21H25FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1D0W98U1I4, chemically known as 1-butanone, 1-(4-fluorophenyl)-4-(4-(2-methoxyphenyl)-1-piperazinyl)- (9ci) but generally known as fluanisone, which bears US NIH Compound Identifier 15139. European Medicines Agency schedules Fluanisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07662MIG. The term FLUANISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules fluanisone in its Anatomical Therapeutic Chemical (ATC) Classification. FLUANISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluanisone under HS 29335995 and SITC 51576. As of Q4 2014, FLUANISONE remains the US FDA Preferred Term for this commodity. Fluanisone bears US NLM identifiers UMLS ID C0060473 and NCI Concept Code C65704. SMILES: FC1CCC(C(=O)CCCN2CCN(CC2)C2C(OC)CCCC2)CC1.

